Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/28/2025 | Sell | Henderson, Jeffrey William | Director | $60.7 | $271,467 |
| 4/1/2025 | Sell | Henderson, Jeffrey William | Director | $64.1 | $32,217 |
| 3/3/2025 | Sell | Henderson, Jeffrey William | Director | $58.5 | $293,459 |
| 2/27/2025 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $58.5 | $98,902 |
| 2/26/2025 | Sell | Labarre, Michael J. | SVP, CHIEF TECHNICAL OFFICER | $58.4 | $581,244 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)